Archives

The following resources are to help learn about scientific aspects of HIV. ART in pictures: HIV treatment explained (2017) Clinical trials: a guide to HIV research (2015) HIV genome – excellent resource that explains the genetic structure of HIV. Science learning modules …

An updated schedule of future national and international medical conferences and workshops is publish in each issue of HTB. HTB future conference listing. HTB includes coverage from most major meetings with reports categorised by subject and meeting. Previous reports in …

Studies to watch and early reports from the large HIV conference in Paris…

Next generation of HIV treatments – including studies to watch for at IAS 2017…

Generic abacavir in the UK, Option B+ in Malawi, new HIV pipeline from CROI, new ARVs, selected peer review reports and more…

Also in Russian. NOTE: this links to the latest update (2021). A new i-Base resource explaining HIV and ART. Read this guide online Download ART in pictures PDF (1.3 Mb) Order print copies (free in UK) This 32-page publication explains HIV and treatment …

DHICE Project (Databases for HIV: Integration, Collaboration, Engagement) DHICE is a project to encourage collaborative working practice between different HIV cohort projects in the UK. Roy Trevelion, based at i-Base, is the Community Liaison Co-ordinator with the project. Memory works …

neonate – a baby that is 0 to 28 days old.

Reports from 23rd BHIVA conference on sexual health in the UK, and paediatric and cure-related research from CROI 2017… plus new i-Base appeal…

Please click title link for the download page.

Pocket hepatitis C (HCV) guide is a small i-Base leaflet about HCV for people who are also HIV positive. It covers testing, monitoring and treatment – especially with new HCV meds called DAAs (direct acting antivirals). Download pocket HCV – PDF (400 Kb) Order …

14 rapid reports from CROI 2017, plus journal reviews and sexual health in the UK – including drop in HIV diagnoses, PrEP news, and HPV vaccines…

Some ARVs have shown superior or non-inferior efficacy at reduced doses compared to existing recommended ones. These drugs offer improved durability and tolerability, higher bioavailability, lower pill burden, and the potential for fewer side effects. The ARVs are: dolutegravir (DTG), tenofovir alafenamide …

14 rapid reports from Seattle… new drugs, dolutegravir monotherapy studies stopped, paediatric formulations, PrEP failure case, good news from brain scans… more to follow…

Direct acting antiviral – See DAA.

EBD (event based dosing) – a term for taking medicines only at times linked to a relevant event. EDD is also called “on-demand dosing”. For example, EBD for PrEP (to prevent HIV transmission) involves taking PrEP before sex and then for several days after …

event-based dosing –  See EBD.

LTNP / LTSP – See: long-term non-progressor.

TasP (Treatment as Prevention) – a term to emphasise the impact that HIV drugs (ART) has on dramatically reducing the chance of HIV transmission. ART is firstly for the health of the HIV positive person. But having an undetectable viral load …

PrEP (Pre-Exposure Prophylaxis) – using HIV drugs before sex (and after) to stop the chance of infection. UK guide to UK – a 24-page i-Base guide covering PrEP in detail. How to use PrEP. Buying PrEP online. Essential monitoring tests. Dosing options including …